Prostate oncology Clinical Trials in San Francisco, CA
As of June 2026, 43 paid clinical trials are recruiting for Prostate oncology in San Francisco, California. Prostate oncology research evaluates next-generation hormone therapies, PARP inhibitors, radioligand treatments, and immune-based approaches for localized and advanced disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
43 clinical trials for Prostate oncology
·Clear filters·↓ Download CSV177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
LTFU for All Cell and Gene Therapy Studies
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
A Study of Tarlatamab for People With Prostate Cancer
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Analyzing Clinical Trial Experiences of Prostate Cancer Patients
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Two-fraction HDR Monotherapy for Localized Prostate Cancer
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
64Cu-GRIP B in Patients With Advanced Malignancies
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Mechanisms of Resistance to PSMA Radioligand Therapy
Precision-Based Genomics in Prostate Cancer
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
About research studies in San Francisco
San Francisco has approximately 1,434 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in San Francisco
Researchers run research studies in San Francisco, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of California, San Francisco | Prostate Cancer, Glioblastoma, Parkinson Disease | 318 |
| University of California San Francisco | Breast Cancer, Heart Failure, Multiple Myeloma | 173 |
| Power Life Sciences | Acne, Anorexia, Anorexia Nervosa | 64 |
| UCSF Medical Center-Mission Bay | Recurrent Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Neuroblastoma | 43 |
| Kaiser Permanente-San Francisco | Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Breast Cancer | 38 |
| UCSF | Colorectal Cancer, Gastric Cancer, Tricuspid Valve Disease | 36 |
| UCSF Helen Diller Family Comprehensive Cancer Center | Breast Cancer, Solid Tumor, Adult, Advanced Breast Cancer | 29 |
| Zuckerberg San Francisco General Hospital | Anatomic Stage II Breast Cancer AJCC v8, Cardiovascular Diseases, HIV | 27 |
| California Pacific Medical Center-Pacific Campus | Anatomic Stage II Breast Cancer AJCC v8, Intracranial Meningioma, Lung Non-Small Cell Carcinoma | 26 |
| UCSF Medical Center | Heart Failure, Pulmonary Hypertension, Stroke | 21 |
| University of California | Aortic Valve Regurgitation, Aortic Valve Stenosis, Articular Cartilage | 21 |
| San Francisco VA Medical Center, San Francisco, CA | PTSD, Sleep Initiation and Maintenance Disorders, Aging | 18 |
| University of California, San Francisco (UCSF) | Adenocarcinoma, Pancreatic Ductal, Advanced/Metastatic Cancer, Amyloid Cardiomyopathy | 15 |
| California Pacific Medical Center | Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Melanoma | 14 |
| UCSF Benioff Children's Hospital | 4H Syndrome, ADLD, AGS | 14 |
| San Francisco General Hospital | HIV, HIV Infections, Intracerebral Hemorrhage | 12 |
| San Francisco VA Medical Center | Atopic Dermatitis, Eczema, Abdominal Compartment Syndrome | 12 |
| University of California San Francisco (UCSF) | Advanced Solid Tumors, Melanoma, Advanced Solid Tumor | 11 |
| San Francisco Research Institute | Women Health, Anxiety, Cognitive Decline | 10 |
| UCSF Medical Center-Parnassus | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 10 |
| University of California - San Francisco | Adult Spinal Deformity, Bladder Cancer, Diabetes | 10 |
| Alethios, Inc. | Beverage Intake, Caffeine, Healthy | 9 |
| University of California at San Francisco | Advanced Tumors, Aortic Valve Disease, Aortic Valve Stenosis | 9 |
| University of California San Francisco Medical Center | Chronic Lymphocytic Leukemia (CLL), Cirrhosis, Colorectal Cancer | 8 |
| University of San Francisco | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 7 |
Active & Upcoming Studies in San Francisco (2026)
Recruiting trials in San Francisco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (432 active studies)
- UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations · University of California, San Francisco
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
Cardiovascular (91 active studies)
- Naloxone for Opioid Associated Out of Hospital Cardiac Arrest · Phase 2 · University of California, San Francisco
- Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) · Phase 2 · Stanford University
Neurology & pain (81 active studies)
- Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy · Phase 1, Phase 2 · University of California, San Francisco
- A Transdiagnostic Sleep Health Intervention for Veterans With PTSD · VA Office of Research and Development
HIV / STI (50 active studies)
- Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs · University of California, San Francisco
- Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study · Phase 4 · University of California, San Francisco
Mental health & behavior (50 active studies)
- Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs · University of California, San Francisco
- Facilitating Transition to Recommended PTSD Treatment · VA Office of Research and Development
Diabetes & metabolic (38 active studies)
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese · Phase 2 · Biomed Industries, Inc.
- Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes · University of California, San Francisco
Pediatric (22 active studies)
- Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children · Duke University
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
Eye & vision (20 active studies)
- Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes · University of California, San Francisco
- Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center · University of California, San Francisco
Vaccines (13 active studies)
- Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC) · EARLY_Phase 1 · University of California, Davis
- A Study to Assess Anktiva in Patients With Long Covid-19. · Phase 2 · ImmunityBio, Inc.
Common conditions studied in San Francisco
- Breast Cancer (28 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Prostate Cancer (27 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Heart Failure (18 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- HIV (16 active studies). HIV trials investigate long-acting injectable antiretrovirals, broadly neutralizing antibodies, and cure-focused strategies.
- Cancer (15 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Glioblastoma (15 active studies). Glioblastoma studies investigate tumor-treating fields, targeted small molecules, and immunotherapy combinations for this aggressive brain cancer.
Leading research sponsors in San Francisco
- University of California, San Francisco
- Power Life Sciences Inc.
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in San Francisco. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in San Francisco
Hipa.ai aggregates every recruiting study in San Francisco from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in San Francisco?
There are approximately 1,434 recruiting clinical trials in San Francisco, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in San Francisco pay participants?
Most recruiting trials in San Francisco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in San Francisco?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in San Francisco?
The most common conditions under active study in San Francisco include Breast Cancer (28), Prostate Cancer (27), Heart Failure (18), HIV (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in San Francisco?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in San Francisco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in San Francisco?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in San Francisco?
Recruiting research sites in San Francisco include University of California, San Francisco, University of California San Francisco, Power Life Sciences, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in San Francisco right now?
The largest active categories in San Francisco are Cancer & tumors (432), Cardiovascular (91), Neurology & pain (81). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.